ID

37019

Description

Autologous Mesenchymal Stromal Cells for Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT02495766

Link

https://clinicaltrials.gov/show/NCT02495766

Keywords

Versions (1)
  1. 6/30/19 6/30/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 30, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Relapsing-Remitting Multiple Sclerosis NCT02495766

English

Eligibility Relapsing-Remitting Multiple Sclerosis NCT02495766

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients between 18 and 60 years of age
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
patients with ms
Description

Multiple Sclerosis

Data type

boolean

Alias
UMLS CUI [1]
C0026769
relapsing-remitting or secondary progressive ms
Description

Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive

Data type

boolean

Alias
UMLS CUI [1]
C0751967
UMLS CUI [2]
C0751965
patients to whom are not indicated or are not in a position to initiate treatment with disease-modifying drugs
Description

Indication Absent Biological Response Modifier Therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0005527
expanded disability status scale (edds) score <6.5
Description

EDSS

Data type

boolean

Alias
UMLS CUI [1]
C0451246
nine t2 lesions at least
Description

Lesion T2 Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0221198
UMLS CUI [1,2]
C3472340
UMLS CUI [1,3]
C1265611
active multiple sclerosis as defined either by 1 outbreak in the last year or at least one gadolinium-enhancing lesion in the last 6 months
Description

Multiple Sclerosis | Event Quantity Past Year | Gadolinium-Enhancing Lesion Quantity

Data type

boolean

Alias
UMLS CUI [1]
C0026769
UMLS CUI [2,1]
C0441471
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C4086728
UMLS CUI [3,1]
C1333400
UMLS CUI [3,2]
C1265611
signed informed consent form
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
interferon beta or glatiramer acetate 3 months prior the screening
Description

Interferon-beta | glatiramer acetate

Data type

boolean

Alias
UMLS CUI [1]
C0015980
UMLS CUI [2]
C0289884
natalizumab or fingolimod in the 6 months prior the screening
Description

natalizumab | fingolimod

Data type

boolean

Alias
UMLS CUI [1]
C1172734
UMLS CUI [2]
C1699926
mitoxantrone, cyclophosphamide or other immunosuppressive therapy at any time
Description

Mitoxantrone | Cyclophosphamide | Therapeutic immunosuppression

Data type

boolean

Alias
UMLS CUI [1]
C0026259
UMLS CUI [2]
C0010583
UMLS CUI [3]
C0021079
has received an experimental treatment within 3 months prior the screening
Description

Therapy, Investigational

Data type

boolean

Alias
UMLS CUI [1]
C0949266
ms outbreak within the 4 weeks prior the randomization
Description

Multiple Sclerosis Event Recent

Data type

boolean

Alias
UMLS CUI [1,1]
C0026769
UMLS CUI [1,2]
C0441471
UMLS CUI [1,3]
C0332185
serum creatinine> 2.0 mg/dl
Description

Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0201976
infectious disease active or uncontrolled
Description

Communicable Disease | Communicable Disease Uncontrolled

Data type

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C0205318
fertile patients who are not using a suitable method of contraception
Description

Patients Fertile | Contraceptive methods Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0015895
UMLS CUI [2,1]
C0700589
UMLS CUI [2,2]
C0332197
pregnant or lactating woman
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
immunodeficiency
Description

Immunodeficiency

Data type

boolean

Alias
UMLS CUI [1]
C0021051
positive serology to hiv, hepatitis b, hepatitis c or syphilis
Description

HIV Seropositivity | Hepatitis B Seropositive | Hepatitis C Seropositive | Syphilis Seropositive

Data type

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2,1]
C0019163
UMLS CUI [2,2]
C0521143
UMLS CUI [3,1]
C0019196
UMLS CUI [3,2]
C0521143
UMLS CUI [4,1]
C0039128
UMLS CUI [4,2]
C0521143
Back to the top of the page

Similar models

Eligibility Relapsing-Remitting Multiple Sclerosis NCT02495766

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
patients between 18 and 60 years of age
boolean
C0001779 (UMLS CUI [1])
Multiple Sclerosis
Item
patients with ms
boolean
C0026769 (UMLS CUI [1])
Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive
Item
relapsing-remitting or secondary progressive ms
boolean
C0751967 (UMLS CUI [1])
C0751965 (UMLS CUI [2])
Indication Absent Biological Response Modifier Therapy
Item
patients to whom are not indicated or are not in a position to initiate treatment with disease-modifying drugs
boolean
C3146298 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0005527 (UMLS CUI [1,3])
EDSS
Item
expanded disability status scale (edds) score <6.5
boolean
C0451246 (UMLS CUI [1])
Lesion T2 Quantity
Item
nine t2 lesions at least
boolean
C0221198 (UMLS CUI [1,1])
C3472340 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Multiple Sclerosis | Event Quantity Past Year | Gadolinium-Enhancing Lesion Quantity
Item
active multiple sclerosis as defined either by 1 outbreak in the last year or at least one gadolinium-enhancing lesion in the last 6 months
boolean
C0026769 (UMLS CUI [1])
C0441471 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C4086728 (UMLS CUI [2,3])
C1333400 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
Informed Consent
Item
signed informed consent form
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Interferon-beta | glatiramer acetate
Item
interferon beta or glatiramer acetate 3 months prior the screening
boolean
C0015980 (UMLS CUI [1])
C0289884 (UMLS CUI [2])
natalizumab | fingolimod
Item
natalizumab or fingolimod in the 6 months prior the screening
boolean
C1172734 (UMLS CUI [1])
C1699926 (UMLS CUI [2])
Mitoxantrone | Cyclophosphamide | Therapeutic immunosuppression
Item
mitoxantrone, cyclophosphamide or other immunosuppressive therapy at any time
boolean
C0026259 (UMLS CUI [1])
C0010583 (UMLS CUI [2])
C0021079 (UMLS CUI [3])
Therapy, Investigational
Item
has received an experimental treatment within 3 months prior the screening
boolean
C0949266 (UMLS CUI [1])
Multiple Sclerosis Event Recent
Item
ms outbreak within the 4 weeks prior the randomization
boolean
C0026769 (UMLS CUI [1,1])
C0441471 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
Creatinine measurement, serum
Item
serum creatinine> 2.0 mg/dl
boolean
C0201976 (UMLS CUI [1])
Communicable Disease | Communicable Disease Uncontrolled
Item
infectious disease active or uncontrolled
boolean
C0009450 (UMLS CUI [1])
C0009450 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Patients Fertile | Contraceptive methods Absent
Item
fertile patients who are not using a suitable method of contraception
boolean
C0030705 (UMLS CUI [1,1])
C0015895 (UMLS CUI [1,2])
C0700589 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating woman
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Immunodeficiency
Item
immunodeficiency
boolean
C0021051 (UMLS CUI [1])
HIV Seropositivity | Hepatitis B Seropositive | Hepatitis C Seropositive | Syphilis Seropositive
Item
positive serology to hiv, hepatitis b, hepatitis c or syphilis
boolean
C0019699 (UMLS CUI [1])
C0019163 (UMLS CUI [2,1])
C0521143 (UMLS CUI [2,2])
C0019196 (UMLS CUI [3,1])
C0521143 (UMLS CUI [3,2])
C0039128 (UMLS CUI [4,1])
C0521143 (UMLS CUI [4,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial